SALT LAKE CITY, UT, Jan. 28, 2013 /PRNewswire/ - American Biotech Labs (ABL) announced today that they have sold more than 10 million units of product containing their revolutionary Nano-silver technology.
"We are proud that people throughout the world have recognized that our patented SilverSol Technology® can make a significant difference in their lives by supporting their immune system," said Keith Moeller, Managing Director. "It has long been our company goal to help families everywhere with our SilverSol® products, and we feel that 10 million units sold to date is an important milestone towards reaching that goal."
"For thousands of years silver has been used for its amazing medicinal properties, but traditional colloidal-type ionic supplements have had some limited negative side effects," added Moeller. "Because of our new SilverSol Technology®, the use of silver as an important immune system support has finally been accepted by both the medical community and the general public."
Recently, what is believed to be the first ever, double-blind, IRB Board controlled, human ingestion study on Nano-silver has been completed on ABL's silver products at a major university. That study is currently in peer review prior to public release.
ABL's SilverSol Technology® is available from healthcare professionals and in quality health food stores nationwide, in both cosmetic topical gels and nutritional supplements. Some of the best-known labels are the Silver Biotics® liquid, ASAP 365™ Silver Gel (a clear topical silver hydrogel), and ASAP HCP™ Health Max.
About American Biotech Labs
Based in Alpine, Utah, American Biotech Labs was formed in 1998 to research and develop a Nano-silver technology that could be easily assimilated and used topically. ABL has committed millions of dollars to research and development of innovative, new Nano-silver products, using this revolutionary technology to improve the health and lives of people throughout the world.
SOURCE American Biotech Labs, LLC